This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Kyoto University, Kyowa Kirin Co., Ltd., Kyowa Kirin Co., Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 871 
1 out of 46 
1 out of 3 Years Active: 2018-2026
Title: Innovations by Kenji Kawada: A Look at His Contributions to Medical Science
Introduction
Kenji Kawada, an accomplished inventor based in Kyoto, Japan, has made significant strides in the field of medical science through his innovative work. With a total of two patents to his name, his contributions focus on advancements in therapeutic and diagnostic methods.
Latest Patents
Kawada's latest patents include an Anti-human CCR1 monoclonal antibody and a method for determining the prognosis of cancer. The anti-human CCR1 monoclonal antibody is designed to bind to the human CC chemokine receptor 1 (CCR1), inhibiting its activation by the chemokine ligand 15 (CCL15). This invention not only includes the antibody but also encompasses its fragments, methods of production, and applications in therapeutic and diagnostic contexts for CCR1-related diseases. His second patent outlines a method for assessing cancer prognosis through the detection of phosphorylation at specific tyrosine residues in TRIO. This method provides crucial information on the cancer's progression and could enhance treatment strategies.
Career Highlights
Kawada has honed his expertise through his tenure at Kyoto University and Kyowa Kirin Co., Ltd. His work has positioned him as a notable figure in medical research, contributing to the development of innovative treatments and methods that can have a lasting impact on patient care.
Collaborations
Throughout his career, Kenji Kawada has collaborated with esteemed colleagues, including Makoto Taketo and Yoshiharu Sakai. These collaborations have fostered an environment of shared ideas and innovations, enhancing the scope and impact of their research.
Conclusion
In conclusion, Kenji Kawada's innovative work epitomizes the essence of advancement in medical technology. His patents on therapeutic agents and diagnostic methods showcase not only his ingenuity but also his commitment to improving healthcare outcomes. His contributions will continue to resonate within the scientific community and beyond, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile